Navigation Links
OmniVision Unveils 1.8 mm, Low Power Medical Sensor With Best-in-Class Low Light Performance

SANTA CLARA, Calif., Nov. 21 /PRNewswire-FirstCall/ -- OmniVision Technologies, Inc. (Nasdaq: OVTI), a leading independent supplier of CMOS image sensors, today introduced the OV6930, the latest addition to its portfolio of medical image sensors. The new low power OV6930 is a 400 by 400 pixel square graphics array, or SquareGA(TM), CMOS image sensor with an optical format of 1/10 inch and a packaged footprint of 1.8 mm x 1.8 mm, making it ideal for camera applications that require less than 2.8 mm outside diameter, such as medical endoscopes for minimally invasive medical procedures.

The OV6930 uses a three micron OmniPixel3-HS(TM) pixel, which enables it to achieve best-in-class low light performance of 3300 mV/Lux-second. Currently, no other CMOS image sensor on the market offers the same high performance and sensitivity in such a small form factor, making the OV6930 a very compelling solution for the medical device market.

"OmniVision's first generation medical sensor (OV6920) has been successfully adopted by multiple customers that have been approved by the FDA or other regulatory agencies worldwide," said Grahame Cooney, Product Marketing Director at OmniVision. "With the OV6930, OmniVision is able to further leverage its success in the medical imaging market. The sensor's size and performance enable an even broader scope of medical endoscopy applications including colonoscopy, gastroscopy, OB/GYN, urology and bronchoscopy."

The OV6930 provides full-frame or cropped analog images in RAW RGB format via the control of a new, patent pending serial I/O, which allows for two-wire cabling up to 14 feet and contributes to its very low power consumption of 80mW with and 10mW without IO usage. It has an image array capable of operating at 30 frames per second (fps) in full 400 x 400 resolution, and 60 fps at 400 x 200 resolution with simplified exposure control, which is programmable through the serial interface. The OV6930 uses proprietary sensor technology to improve image quality by reducing or eliminating common lighting or electrical sources of image contamination, such as fixed pattern noise and smearing, to produce a clean, fully stable color image.

For additional information on OmniVision's medical imaging products, please visit

About OmniVision

OmniVision Technologies designs and markets high-performance semiconductor image sensors. Its CameraChip(TM) products using OmniPixel(R), OmniPixel2(TM), OmniPixel3(TM), OmniPixel3-HS(TM) and OmniBSI(TM) technologies are highly integrated, single-chip CMOS image sensors for mass-market consumer and commercial applications such as mobile phones, notebooks, security and surveillance systems, digital still cameras, automotive and medical imaging systems and interactive video games. Additional information is available at

Safe-Harbor Language

Certain statements in this press release, including statements regarding the expected benefits, performance and capabilities of the OV6930 CMOS image sensors are forward-looking statements that are subject to risks and uncertainties. These risks and uncertainties, which could cause the forward-looking statements and OmniVision's results to differ materially, include, without limitation: potential errors, design flaws or other problems with the OV6930; customer acceptance, demand, and other risks detailed from time to time in OmniVision's Securities and Exchange Commission filings and reports, including, but not limited to, OmniVision's annual report filed on Form 10-K and quarterly reports filed on Form 10-Q. OmniVision expressly disclaims any obligation to update information contained in any forward-looking statement.

OmniPixel(R) is the registered trademarks of OmniVision Technologies, Inc. OmniVision(TM), the OmniVision logo, CameraChip(TM), OmniPixel2(TM), OmniPixel3(TM), OmniPixel3-HS(TM), OmniBSI(TM), and SquareGA(TM) are trademarks of OmniVision Technologies, Inc. All other trademarks are the property of their respective owners.

SOURCE OmniVision Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
2. Wellcorps International Unveils New Nutritional Supplements
3. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
4. Rice unveils $100 million initiative for world health technology
5. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
6. The Well Life Center in Mesa Unveils The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
7. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
8. National Domestic Violence Hotline Unveils 10-Year Blueprint to Significantly Reduce Domestic Violence in America
9. GainSpan Unveils Wi-Fi(R) Sensor Network Solution With Years of Battery Life
10. U.S. Unveils Database of Genetic, Clinical Research
11. Saks Fifth Avenue Unveils Five Magical Holiday Gifts
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: